These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7328483)

  • 1. [Assay and bioavailability of vincamine (author's transl)].
    Jaminet F; Schneck G; Polastro E; Lejeune A
    J Pharm Belg; 1981; 36(6):421-5. PubMed ID: 7328483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)].
    Erking W; Lücker PW; Metz G; Specker M; Wetzelsberger K
    Arzneimittelforschung; 1978; 28(12):2332-6. PubMed ID: 582951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of vincamine in Vinca minor].
    He LY; Zhou JY; Fang QC
    Yao Xue Xue Bao; 1983 Dec; 18(12):925-8. PubMed ID: 6679174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
    Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
    Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the in vitro availability of vincamine from delayed-release forms. 1].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(2):93-9. PubMed ID: 6470921
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interpretation of mean dissolution kinetics in multidimentional analysis. Application to quinidine and vicamine preparations].
    Bastide R; Michaud P; Rouffiac R; Bonnet L
    Pharm Acta Helv; 1978; 53(6):157-69. PubMed ID: 724729
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of vincamine by high-performance liquid chromatography with dual-wavelength ultraviolet detection.
    Amato A; Cavazzutti G; GagliardiL ; Profili M; Zagarese V; Chimenti F; Tonelli D; Gattavecchia E
    J Chromatogr; 1983 Nov; 270():387-91. PubMed ID: 6655023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative determination of drugs by in situ spectrophotometry of chromatograms for pharmacokinetic studies. I. Sulpiride and other benzamides, vincamine, naftazone (author's transl)].
    Bressolle F; Bres J; Brun S; Rechencq E
    J Chromatogr; 1979 Jul; 174(2):421-33. PubMed ID: 546899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescence assay and pharmacokinetics of vincamine in rats (author's transl)].
    Iven H; Siegers CP
    Arzneimittelforschung; 1977; 27(6a):1248-54. PubMed ID: 578449
    [No Abstract]   [Full Text] [Related]  

  • 10. [Absorption, distribution and elimination of vincamine hydrochloride in the rat].
    Vigano V; Rognoni F; Piacenza G; Pesce E
    Farmaco Prat; 1978 May; 33(5):224-31. PubMed ID: 744225
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the pharmacokinetics of vincamine after i.v. and oral application to the dog (author's transl)].
    Laufen H; Juhran W; Fleissig W; Götz R; Scharpf F; Bartsch G
    Arzneimittelforschung; 1977; 27(6a):1255-64. PubMed ID: 20113
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro dissolution test: evaluation criterion for prolonged release dosage forms vincamine example (author's transl)].
    Buri P; Doelker E; Boucherat J
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1310-3. PubMed ID: 7279852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acoustic traumatism with injectable vincamine. Random double blind clinical trial with a complementary comparative element (author's transl)].
    Hennebert D; De Heyn G
    Rev Med Brux; 1982 Jan; 3(1):37-43. PubMed ID: 7038815
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale of using Vinca minor Linne dry extract phytocomplex as a vincamine's oral bioavailability enhancer.
    Hasa D; Perissutti B; Dall'Acqua S; Chierotti MR; Gobetto R; Grabnar I; Cepek C; Voinovich D
    Eur J Pharm Biopharm; 2013 May; 84(1):138-44. PubMed ID: 23238273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vincamine N4-mononitrate (author's transl)].
    Voigtländer HW; Pohl L
    Arch Pharm (Weinheim); 1978 Sep; 311(9):804-6. PubMed ID: 708214
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(3):136-44. PubMed ID: 6481608
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of vincamine on vigilance disorders in the elderly (author's transl)].
    Moreau J
    Sem Hop; 1978 Nov 8-15; 54(37-40):1181-4. PubMed ID: 217102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic action of a combination of vincamine and piracetam in peripheral labyrinthine syndromes with a vascular component].
    Jiménez-Cervantes Nicolás JA; Ferrán Bernal J; Anula Suárez P; Gil Melgarejo JA
    An Otorrinolaringol Ibero Am; 1981; 8(2):131-60. PubMed ID: 7270822
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of vincamine and related compounds.
    Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):89-103. PubMed ID: 3899662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.